Kowa, Lilly (LLY) Report LIVALO Met Primary Endpoint in Reducing LDL-C

March 7, 2013 6:43 AM EST Send to a Friend
Kowa Pharmaceuticals America, Inc. and Eli Lilly and Company (NYSE: LLY) announced results of a study evaluating the efficacy of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login